Understanding the AOD-9604 Peptide: A 2026 Overview

What Is AOD-9604, Exactly?

AOD-9604 (Anti-Obesity Drug 9604) is a synthetic peptide fragment corresponding to amino acids 177-191 of the human growth hormone (hGH) sequence. It contains 15 amino acids and carries a disulfide bridge. Researchers study it primarily for its interactions with lipid metabolism pathways in controlled laboratory settings.

The name itself is a clue. AOD stands for Anti-Obesity Drug, and the compound was originally numbered 9604 during pharmaceutical development at Monash University in Australia during the 1990s. The peptide mirrors the C-terminal region of hGH, specifically residues 177 through 191.

That 15-amino-acid stretch is short enough to synthesize with high reproducibility, which is one reason it appears so often in published peptide research. The disulfide bridge between cysteine residues at positions 182 and 189 gives the molecule structural stability that a simple linear fragment would lack.

In laboratory models, researchers have examined how AOD-9604 interacts with beta-3 adrenergic receptors and lipolysis pathways. Those interactions are the subject of ongoing peer-reviewed investigation. No approved therapeutic use exists as of 2026, and the compound is classified strictly as a research-grade peptide.

The Molecular Structure Behind the Research Interest

AOD-9604 has the molecular formula C78H123N23O23S2 and a molecular weight of approximately 1817.0 Da. Its disulfide bridge and hydrophobic C-terminal tail are structurally distinct from intact human growth hormone, which is why researchers treat it as an independent study compound rather than a simple hGH analog.

Molecular weight of roughly 1817 daltons puts AOD-9604 in the mid-range for synthetic research peptides. That size makes it amenable to standard analytical techniques without the complexity of larger biologics.

High-Performance Liquid Chromatography (HPLC) is the primary tool used to confirm purity. A quality batch typically shows a single dominant peak at greater than 98% purity by reverse-phase HPLC. Mass Spectrometry (MS) then confirms molecular identity by verifying the observed mass matches the theoretical value within accepted tolerance, usually plus or minus 0.1 Da.

The disulfide bridge deserves attention. If oxidation conditions during synthesis are poorly controlled, mixed disulfide isomers can form, reducing batch purity and reproducibility. A complete Certificate of Analysis (COA) from a reputable supplier will call out disulfide bond formation explicitly, not just report a purity number.

How AOD-9604 Is Used in Laboratory Research

In controlled laboratory research, AOD-9604 is studied for its effects on lipid metabolism, fat cell signaling, and beta-adrenergic receptor activity. Typical study designs use in vitro cell models or rodent models, with researchers measuring biomarkers such as free fatty acid release, adipocyte response, and metabolic rate changes.

Most published studies on the AOD-9604 peptide use one of two broad experimental designs. The first is in vitro work with adipocyte cell lines, where researchers add the compound at defined concentrations and measure lipolytic responses. The second is in vivo rodent modeling, which tracks metabolic parameters over a controlled feeding period.

Researchers also study AOD-9604 in the context of cartilage and bone metabolism. A handful of peer-reviewed papers from the 2000s and 2010s examined chondrocyte responses in vitro. This broadens the peptide's relevance beyond pure metabolic research and partially explains the sustained academic interest through 2026.

One important practical note: AOD-9604 is for laboratory research use only. It is not approved for human or veterinary therapeutic use. Any institutional protocol using this compound should have ethics board review where required by applicable regulations.

What to Look for in a Quality COA

A complete AOD-9604 Certificate of Analysis should include: (1) peptide sequence confirmation, (2) HPLC purity result and chromatogram, (3) MS identity confirmation with observed vs. theoretical mass, (4) batch and lot number, (5) manufacturing date and recommended storage conditions, and (6) microbial testing results where applicable.

Not all COAs are equal. Some suppliers publish a purity number with no supporting chromatogram. That's a red flag. A rigorous COA gives you the raw data to evaluate yourself, not just a pass/fail stamp.

Here's a practical checklist for reviewing an AOD-9604 COA:

• Sequence confirmation: The amino acid sequence 177-191 of hGH should be explicitly stated.
• HPLC purity: Look for a reverse-phase HPLC chromatogram alongside the numeric purity result. Values below 98% warrant scrutiny.
• Mass spec data: The observed molecular ion should match the theoretical mass within plus or minus 0.1 Da. The COA should state both numbers.
• Batch/lot number: Traceability requires a unique identifier you can reference if questions arise later.
• Manufacturing and expiry dates: Lyophilized peptides are not indefinitely stable. Confirm the batch is within its tested shelf life.
• Microbial screening: For any study involving cell culture, endotoxin and microbial contamination results are worth requesting explicitly.

Peptide Validation Certified Vendors are assessed against criteria that include transparent COA availability, independent third-party lab verification, and documented quality management systems. Checking a vendor against those standards before you place your first order is a faster route to reliable results than troubleshooting bad batches after the fact.

Handling lyophilized peptides correctly is one of those skills that separates clean data from noisy data. The freeze-drying process creates a fragile cake structure that dissolves easily, but aggressive handling introduces bubbles and potential degradation.

Start by removing the vial from cold storage and letting it equilibrate to room temperature for 5 to 10 minutes. This prevents condensation from forming inside the vial when you open it, which can introduce moisture and accelerate degradation.

Common Research Questions About AOD-9604

A few questions come up repeatedly among researchers encountering the AOD-9604 peptide for the first time.

Does AOD-9604 activate the GH receptor? Published data suggests it does not bind the classical GH receptor with meaningful affinity at the concentrations used in most laboratory studies. The proposed mechanism runs through beta-adrenergic pathways instead. This distinction is relevant when designing assay controls.

How does it compare to fragment 176-191? You'll sometimes see AOD-9604 described interchangeably with hGH fragment 176-191. The fragments overlap almost entirely. The Monash University formulation carried a tyrosine residue at position 177 and was acetylated at the N-terminus in some preparations, producing slight mass differences. Always verify which exact sequence and modification status your batch carries by reading the COA sequence confirmation line.

What causes batch-to-batch variability? Synthesis conditions, resin quality, cleavage chemistry, and purification steps all contribute. This is why independent third-party HPLC and MS testing by the vendor, not just in-house quality checks, gives researchers stronger confidence in consistency.

For a deeper breakdown of the compound's history, analytical standards, and vendor selection criteria, see the full AOD-9604 research guide linked at the end of this article.

Setting Up Your Research Protocol: Key Steps

Solid protocols start before the peptide leaves the freezer. Here is a practical sequence for labs preparing an AOD-9604 experiment.

Step 1: COA review. Pull the batch-specific COA and confirm HPLC purity, MS identity, and storage requirements before signing off on the order. If the COA is missing any of those three elements, request them from the vendor.

Step 2: Storage verification. Confirm your freezer is holding steady at minus 20 degrees Celsius. A single temperature excursion of several hours above 4 degrees Celsius can meaningfully affect lyophilized peptide stability.

Laboaratories that treat analytical documentation as a step in the experiment, not an afterthought, produce more reproducible data. That principle applies to every research peptide, and AOD-9604 is no exception.

Frequently asked questions

What is the AOD-9604 peptide used for in research?

AOD-9604 is a synthetic peptide fragment of human growth hormone (residues 177-191) studied in controlled laboratory settings for its interactions with lipid metabolism, beta-adrenergic signaling, and adipocyte biology. It is not approved for any human or veterinary therapeutic use as of 2026 and is classified strictly as a research-grade compound.

What does AOD-9604 stand for?

AOD stands for Anti-Obesity Drug. The compound was assigned the development number 9604 during pharmaceutical research at Monash University in Australia in the 1990s. The name reflects the original research focus on metabolic and body composition endpoints in laboratory models.

What purity level should a research-grade AOD-9604 batch have?

Research-grade AOD-9604 should demonstrate a purity of at least 98% by reverse-phase HPLC analysis. The Certificate of Analysis should include a chromatogram alongside the numeric result, plus mass spectrometry confirmation that the observed molecular weight matches the theoretical value of approximately 1817.0 Da.

Is AOD-9604 the same as hGH fragment 176-191?

The terms are often used interchangeably, but small differences exist. The Monash University AOD-9604 formulation included a tyrosine at position 177 and in some preparations had N-terminal acetylation, producing slight mass differences from a standard fragment 176-191. Always confirm the exact sequence and modification status on the batch-specific COA before use.

How do I verify the quality of an AOD-9604 supplier?

Check that the supplier provides batch-specific Certificates of Analysis with HPLC chromatograms, mass spectrometry identity confirmation, lot numbers, and manufacturing dates. Independent third-party laboratory testing, transparent sourcing documentation, and a documented quality management system are the key markers of a credible research peptide vendor.

Related in this series

• How to Research AOD-9604 Peptide: Lab Techniques